| Company/Division name | PENDING TARIFFS - Abbvie |
| Parent company | PENDING TARIFFS - AbbVie |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2026 |
| Capital investment ($): | 10,000 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |
